Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vexim brings in financial expertise in-house for expansion

This article was originally published in Clinica

Executive Summary

French spinal technology firm Vexim has appointed Jérôme Marzinski deputy CEO. Mr Marzinski has a solid background in finance and within medtech; he has worked for vascular implants firm ev3, where he joined as international finance manager and was then promoted to European general manager. Following the acquisition of ev3 by Covidien and prior to joining Vexim, Mr Marzinski worked as a medtech consultant. He will report to the CEO of Vexim, Vincent Gardès. The Toulouse-based company is ramping up European commercialization of its SpineJack minimally invasive device for treating vertebral compression fractures.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT100943

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel